New Inhalation Therapies- Evaluate the data used to support the approval of aztreonam lysine for inhalation in cystic fibrosis. Describe the underlying rationale and data from clinical trials of dry powder mannitol in cystic fibrosis. Describe the rationale and data from clinical trials supporting the use of denufosol.
1 Contact Hour for Respiratory Therapists
This course is sponsored by Johns Hopkins University; to see if your state accepts CME for RT credit for license renewal-
CLICK HERE!